Sales 2024 * | 22.15M 27.68M 2.31B | Sales 2025 * | 36.37M 45.44M 3.79B | Capitalization | 813M 1.02B 84.74B |
---|---|---|---|---|---|
Net income 2024 * | -42M -52.48M -4.38B | Net income 2025 * | -72M -89.97M -7.51B | EV / Sales 2024 * | 32.6 x |
Net cash position 2024 * | 91.29M 114M 9.52B | Net cash position 2025 * | 82.95M 104M 8.65B | EV / Sales 2025 * | 20.1 x |
P/E ratio 2024 * |
-46.8
x | P/E ratio 2025 * |
-33.6
x | Employees | 109 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 0% |
Latest transcript on Silence Therapeutics plc
Managers | Title | Age | Since |
---|---|---|---|
Craig Tooman
CEO | Chief Executive Officer | 58 | 06/21/06 |
Director of Finance/CFO | 52 | 01/21/01 | |
Curtis Rambaran
CTO | Chief Tech/Sci/R&D Officer | - | 01/21/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Steven Romano
CTO | Chief Tech/Sci/R&D Officer | 64 | 29/19/29 |
David Lemus
BRD | Director/Board Member | 61 | 21/18/21 |
Iain Ross
CHM | Chairman | 71 | 02/04/02 |